ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2011

Utilities and disutilities for attributes of injectable treatments for type 2 diabetes.

Kristina S Boye et al.PubMed ↗Publisher ↗

No numbers read from the abstract.